Return to Publications
RWJBarnabas HealthRutgers Cancer Institute, along with its partner RWJBarnabas Health, offers the most advanced cancer treatment options including clinical trials and novel therapeutics such as precision medicine and immunotherapy.

Return to Publications  |  Return to CINJ Home
Rutgers Cancer Institute of New Jersey's Cancer Connection, December 2015
Donate NowThe latest news on research, treatment, prevention and education from the
state's only National Cancer Institute-designated Comprehensive Cancer Center


Give now

December 1st is Rutgers Giving Day! Aligned with the national #GivingTuesday movement, the Rutgers community is challenging itself to see how much support it can garner in just one day by participating in a 24-hour online fundraising event. Rutgers Giving Day is an opportunity to support Rutgers Cancer Institute of New Jersey. Show your passion for research, education, and patient care programs at Rutgers Cancer Institute by visiting to make your donation today. Give now

'New Jersey Monthly' Magazine Names Rutgers Cancer Institute Doctors Among the State's Best


Top Docs

Considered leaders in their field across the state, several physicians at Rutgers Cancer Institute of New Jersey have been named as a 'Jersey Choice Top Doctor' by New Jersey Monthly magazine. Areas of expertise include surgical oncology, gynecologic oncology, radiation oncology, hematologic oncology and urologic oncology. Rutgers Cancer Institute physicians are also faculty members at Rutgers Robert Wood Johnson Medical School.Learn who's on the list

Teaming up with the Big Ten Cancer Research Consortium to Tackle Kidney Cancer



In collaboration with the Big Ten Cancer Research Consortium, Rutgers Cancer Institute of New Jersey has opened a clinical trial for patients with metastatic kidney cancer. The study is examining a combination of pembrolizumab, a type of drug known as a "checkpoint" inhibitor, with bevacizumab. Rutgers Cancer Institute urologic oncologist Eric A. Singer, MD, MA, FACS, an assistant professor of surgery at Rutgers Robert Wood Johnson Medical School, is the lead investigator at Rutgers Cancer Institute.Learn more

$50,000 Childhood Cancer Research Grant Awarded to Rutgers


St. Baldrick's

The St. Baldrick's Foundation, which is dedicated to raising money for childhood cancer research, has awarded a $50,000 grant to Rutgers Cancer Institute of New Jersey to help increase the participation of adolescent and young adult cancer patients (ages 15 to 39) in cancer clinical trials. The grant will help support the addition of a dedicated Clinical Research Nurse at Rutgers Cancer Institute to assist with clinical trial accrual.Learn more

Examining a Cell Survival Mechanism in the Development of Lung Cancer



Rutgers Cancer Institute of New Jersey researcher 'Jessie' Yanxiang Guo, PhD, has received a $628,884 grant from the National Cancer Institute to investigate the role of a cell survival mechanism known as autophagy in lung cancers. Dr. Guo, who is also an assistant professor of medicine at Rutgers Robert Wood Johnson Medical School, will examine lung cancers driven by the active Kras protein, which is responsible for cell division. The aim is to provide a new strategy for lung cancer treatment.Learn more

            Rutgers Cancer Institute of New Jersey                                          NCI logo 

Office of Communications         ·        ·        732-235-9871

                        Like us on Facebook                     Join the CINJ Mailing List